Anlon Healthcare Ltd (AHCL) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

1.97 lacs (5,815.76%) Volume

Shareholding (Aug 2025)

FII

0.00%

Held by 0 FIIs

DII

29.74%

Held by 1 DIIs

Promoter

70.26%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 828 Cr (Micro Cap)

P/E

40.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.07

Return on Equity

9.57%

Price to Book

3.84

Revenue and Profits:

Net Sales:

52 Cr

(Quarterly Results - Sep 2025)

Net Profit:

9 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

69.44%

6 Months

0.0%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Anlon Healthcare for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

No Recent News for the Company

Announcements

Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

02-Dec-2025 | Source : BSE

We have attached herewith announcement as per Reg. 30 of SEBI (LODR) Regulation 2015 for Share Purchase Agreement executed between the Anlon Healthcare Limited and Apiqo Organics Private Limited (Formerly known as M/s Apple Life Science a Partnership Firm). Kindly take the same on your record. Thank you.

Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

28-Nov-2025 | Source : BSE

We have attached herewith announcement as per Reg. 30 of SEBI (LODR) Regulation 2015 for Share Purchase Agreement executed between the Anlon Healthcare Limited and Bizotic Life Science Private Limited. Kindly take the same on your record. Thank you.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

25-Nov-2025 | Source : BSE

We have attached herewith Intimation regarding Investor (s)/Analyst (s) meet. Kindly take the same on your record. Thank you.

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

65.60%

EBIT Growth (5y)

58.45%

EBIT to Interest (avg)

8.18

Debt to EBITDA (avg)

2.57

Net Debt to Equity (avg)

0.70

Sales to Capital Employed (avg)

0.86

Tax Ratio

23.69%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

2.83%

ROCE (avg)

9.07%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.84

EV to EBIT

27.49

EV to EBITDA

25.98

EV to Capital Employed

3.66

EV to Sales

6.96

PEG Ratio

Dividend Yield

ROCE (Latest)

13.30%

ROE (Latest)

9.57%

Technicals key factors

Indicator

Weekly

Monthly

No records

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Aug 2025

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Punitkumar R Rasadia (34.98%)

Highest Public shareholder

Neomile Corporate Advisory Limited (7.92%)

Individual Investors Holdings

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 56.76% vs 37.77% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 162.54% vs 37.07% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "52.20",
          "val2": "33.30",
          "chgp": "56.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13.73",
          "val2": "6.24",
          "chgp": "120.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.87",
          "val2": "0.82",
          "chgp": "6.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "9.32",
          "val2": "3.55",
          "chgp": "162.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.30%",
          "val2": "18.74%",
          "chgp": "7.56%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "85.50",
          "val2": "62.00",
          "chgp": "37.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "19.98",
          "val2": "14.45",
          "chgp": "38.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.68",
          "val2": "1.91",
          "chgp": "-12.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "12.86",
          "val2": "6.36",
          "chgp": "102.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.37%",
          "val2": "23.31%",
          "chgp": "0.06%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Jun'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "95.30",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "20.69",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "2.73",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "9.91",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.71%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "120.29",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "32.21",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "3.72",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "20.52",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.78%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ

Sep'25

Jun'25

Change(%)

Net Sales

52.20

33.30

56.76%

Operating Profit (PBDIT) excl Other Income

13.73

6.24

120.03%

Interest

0.87

0.82

6.10%

Exceptional Items

0.00

Standalone Net Profit

9.32

3.55

162.54%

Operating Profit Margin (Excl OI)

26.30%

18.74%

7.56%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2025 is 56.76% vs 37.77% in Jun 2025

Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is 162.54% vs 37.07% in Jun 2025

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

85.50

62.00

37.90%

Operating Profit (PBDIT) excl Other Income

19.98

14.45

38.27%

Interest

1.68

1.91

-12.04%

Exceptional Items

0.00

Standalone Net Profit

12.86

6.36

102.20%

Operating Profit Margin (Excl OI)

23.37%

23.31%

0.06%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Jun'25

Jun'25

Change(%)

Net Sales

95.30

Operating Profit (PBDIT) excl Other Income

20.69

Interest

2.73

Exceptional Items

0.00

Standalone Net Profit

9.91

Operating Profit Margin (Excl OI)

21.71%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'25

Mar'25

Change(%)

Net Sales

120.29

Operating Profit (PBDIT) excl Other Income

32.21

Interest

3.72

Exceptional Items

0.00

Standalone Net Profit

20.52

Operating Profit Margin (Excl OI)

26.78%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About Anlon Healthcare Ltd

Anlon Healthcare Ltd

Micro Cap

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available